OEL Fastrac Catalog

Potassium iodide is an antithyroid agent used for the preoperative management of hyperthyroidism in patients with Graves’ disease undergoing thyroidectomy. It is used in the management of severe, life-threatening thyrotoxicosis in conjunction with other antithyroid agents, β-adrenergic blocking agents, and corticosteroids. Potassium iodide is also used for the blockage of thyroidal uptake of radioactive isotopes of iodine that may be released into the environment (for instance from a nuclear power plant) to minimize the risk of radiation induced thyroid neoplasms related to internal exposures to radioiodine. It is used to protect the thyroid gland during diagnostic or therapeutic use of radiopharmaceuticals or drugs that have radioactive components. Potassium iodide is used for the treatment of cutaneous sporotrichosis and lymphocutaneous sporotrichosis caused by Sporothrix schenckii. Potassium iodide has been used as an expectorant in the symptomatic management of chronic pulmonary diseases where tenacious mucus complicated the condition.

Affygility Solutions has an occupational exposure limit (OEL) and control band assignment for this active pharmaceutical ingredient (API). This monograph also contains the acceptable daily exposure (ADE) value.

Why do you need this OEL Fastrac monograph?

OEL Fastrac monographs are a cost-effective and convenient way to meet the requirements for PDEs (ADEs) contained in the EMA Guideline on setting health based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities (EMA/CHMP/CVMP/SWP/169430/2012), as well as PIC/S and ANVISA requirements, and to obtain the following information:

• The numerical OEL and control band assignment needed to determine the level of required engineering controls and personal protective equipment
• A listing of all cited references utilized in the derivation of the OEL and ADE
• An expert review and discussion with respect to the critical endpoints of concern, the rationale for the choice of endpoints, and dose that is to be used in the derivation of the ADE (PDE), as required by the EMA's Guideline on setting health-based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities

Benefits of OEL Fastrac monographs

• Fully documented. Over 20 pages in length, with calculations and cited references.
• Save time! Unsurpassed delivery with instant download.
• Save money. Similar documents cost 5-12 times as much.
• Stay current. Automatic notification of revisions.

How to order

To order an OEL/ADE monograph for Potassium Iodide, just click the ADD TO CART button.

HBEL

If you're wondering about HBEL, we have something for you.